Astellas Gets Europe Okay For AML Drug Xospata

Pulls Further Ahead Of Daiichi Sankyo's Rival FLT3 Inhibitor

 
• By Kevin Grogan
Check list
Astellas ticks off a third major approval for Xospata • Source: Shutterstock

More from Anticancer

More from Therapeutic Category